Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001078782-15-001492
Filing Date
2015-09-18
Accepted
2015-09-17 18:52:57
Documents
4
Effectiveness Date
2015-09-18

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE 14A ADDITIONAL MATERIALS defa14a091415_defa14a.htm DEFA14A 13864
2 IMAGE defa14a091415_defa14a001.jpg GRAPHIC 166946
3 IMAGE defa14a091415_defa14a002.jpg GRAPHIC 258862
4 IMAGE defa14a091415_defa14a003.jpg GRAPHIC 133523
  Complete submission text file 0001078782-15-001492.txt   784610
Mailing Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208
Business Address 1 SCOTTS RD #24-05 SHAW CENTRE SINGAPORE U0 228208 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

EIN.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36833 | Film No.: 151113690
SIC: 2835 In Vitro & In Vivo Diagnostic Substances